News | March 13, 2025
Alkem launches generic empagliflozin and its combinations in India under ‘Empanorm’
Empagliflozin is used in the treatment of type-2 diabetes mellitus, chronic kidney disease and heart failure
Empagliflozin is used in the treatment of type-2 diabetes mellitus, chronic kidney disease and heart failure
Methenamine Hippurate tablets are indicated for prophylactic or suppressive treatment of frequently recurring urinary tract infections
Announces Rs. 317 crore investment in new recycling plant
Overall investment in the US facility is estimated around US$50 million
Vidya will spark conversations around less discussed and important aspects of health, including intimate care and sleep issues
The study demonstrated equivalent efficacy, safety, immunogenicity, and pharmacokinetics between YESINTEK and the reference product Stelara
There are 38.4 million people with diabetes in the United States
Dasatinib is indicated for the treatment of newly diagnosed adults with Philadelphia chromosome-positive (Ph+) chronic myeloid leukaemia (CML) in chronic phase
The company will provide the necessary response on these observations to USFDA within stipulated 15 days
Jadhav has completed his B.Pharmacy and is having 30+ years of rich experience in operation management in pharmaceutical Industry
Subscribe To Our Newsletter & Stay Updated
